✦ LIBER ✦

The promises of personalized medicine

✍ Scribed by Ingolf Cascorbi

Publisher: Springer
Year: 2010
Tongue: English
Weight: 113 KB
Volume: 66
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s00228-010-0858-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Personalized cancer medicine and the fut

Personalized cancer medicine and the future of pathology

✍ H. Moch; P. R. Blank; M. Dietel; G. Elmberger; K. M. Kerr; J. Palacios; F. Penau 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 239 KB

On the bumpy road towards ‘personalized

On the bumpy road towards ‘personalized medicine’

✍ Uta Francke 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Personalized medicine and the genotype–p

Personalized medicine and the genotype–phenotype dilemma

✍ Dan M. Roden 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 177 KB

HGV2011: Personalized genomic medicine m

HGV2011: Personalized genomic medicine meets the incidentalome

✍ Melissa A. Wilson Sayres; Anthony J. Brookes; Stephen J. Chanock; Vivian G. Cheu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

The 12th International Meeting on Human Genome Variation and Complex Genome Analysis (HGV2011: Berkeley, California, USA, 8th-10th September 2011) was a stimulating workshop where researchers from academia and industry explored the latest progress, challenges, and opportunities in genome variation r

Overview of the Development of Personali

Overview of the Development of Personalized Genomic Medicine and Surgery

✍ F. Charles Brunicardi; Richard A. Gibbs; David A. Wheeler; John Nemunaitis; Will 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 241 KB

Getting to personalized cancer medicine

Getting to personalized cancer medicine : Taking out the garbage

✍ Carolyn Compton 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

T he vision of personalized medicine is a compelling one for the future of medical care in general and cancer care in specific. It foresees the use of molecular data to better classify disease, facilitate the development and validation of new targeted therapies, treat patients with more specificity